The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
We are selling in India..
We are weeks away from signing a contract with the UK government to supply 200,000 antibody tests per week.
Presentation clearly meant nothing Sam? It's up 10% you fool.
Roxbury, the CEO clearly stated yesterday tests have been shipped to India..
You are an idiot pal.
It's moving 12% Legin.. wtf are you onabout pal
If you have a car racing towards you and you know that the car has faulty brakes (BOD), do you patiently stand still in the hope the brakes may at some point kick in or do you get yourself out the ****ing way. Sort of what people are doing here by staying invested. I'd rather lose out on a few % at the start of a spike than lose multiple 10%'s up until that point.
It is, I made fairly significant losses on this share and I kept trading out and in hoping for the spike to make up for the previous loss. I got in the day after the £3 spike at about £1.85 thinking, this is an easy bounce.. if I had held this entire time I'd be withdrawing pennies.
I beg to differ.
I dunno, but you've got to change something otherwise your money will keep plummeting. ODX will be the sole distributor the UK gov.. ODX are already in India. Let's face it, GDR have an incompetent BOD and that won't change anytime soon.
Anyway, each to their own.
Cheers.
You're welcome JAdam.
Going up by 12p will be a big % increase but not that dramatic when considering...
Unusual for a COVID stock at the minute..
Will only dip though, typical covid stock but by the end of the day should be retracing up.
Incredible activity - let's keep it up during the morning rise. 38 today I see as reasonable following yesterday's presentation.
ELISA
First commercial sales (Senegal). Evaluation currently being undertaken in 18 countries, expecting completion next month. They now have India approval and are free to sell. Products have now been shipped to Indian, expecting sales towards end of this month and August.
Sale price - £1.50 with 50% margin.
POC Testing
Product will be ready end of August, commercial sales expected late September, early October.
Sale price - £3.20 with 50% margin.
Antibody Testing
Continuing to progress through verification and validation, then regulatory approval will be pursued. Expecting to commence supply in September (100,000 per week initially, 200,000 per week end of October – required as part of consortium)
Sale price -£1.50 with 50% margin.
SP = £1.50/ 50% margin.
Expecting to conclude UK government contract negotiations end of July/ Early August. This will allow for distribution outside of the UK gov but is likely to be subject to the UK gov receiving capacity on a first come first serve basis.
Developing an app to assist with tracking results.
:)
Clear you don't like been corrected, not a great trait!
I'm getting in. FOMO has got me. In any scenario, natural bounce should occur to make me a reasonable profit, even if it doesn't stay there.
You mean Dengue?
Just to be clear.